Abnormal hypermethylation and clinicopathological significance of Axin gene in lung cancer

Tumor Biology

Volumn 34, Issue 2, 2013, Pages 749-757

  Yang, Lian He ^a   Xu, Hong Tao ^a   Li, Qing Chang ^a   Jiang, Gui Yang ^a   Zhang, Xiu Peng ^a   Zhao, Huan Yu ^a   Xu, Ke ^a   Wang, En Hua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Axin; Growth; Invasion; Methylation; Wnt

Indexed keywords

AXIN; MESSENGER RNA; 5 AZA 2' DEOXYCYTIDINE; AXIN1 PROTEIN, HUMAN; AZACITIDINE; DRUG DERIVATIVE;

ADULT; ARTICLE; AXIN GENE; CANCER CELL; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INHIBITION; CELL STRAIN; CELL STRAIN BE1; CELL STRAIN H460; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE SEQUENCE; GENOMICS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; LUNG PARENCHYMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; TUMOR INVASION; UPREGULATION; ADENOCARCINOMA; CANCER STAGING; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; FEMALE; GENE SILENCING; GENETICS; LARGE CELL CARCINOMA; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE; WESTERN BLOTTING;

ADENOCARCINOMA; AXIN PROTEIN; AZACITIDINE; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, LARGE CELL; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 84877112180     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0604-z     Document Type: Article

References (24)

1. Lustig B, Behrens J. The Wnt signaling pathway and its role in tumor development. Clin Oncol. 2003;129(4):199-221.
2. Salahshor S, Woodgett JR. The links between axin and carcinogenesis. J Clin Pathol. 2005;58(3):225-36.
3. Xu HT, Wang L, Lin D, Liu Y, Liu N, Yuan XM, et al. Abnormal beta-catenin and reduced axin expression are associated with poor differentiation and progression in non-small cell lung cancer. Am J Clin Pathol. 2006;125(4):534-41.
4. Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry 3rd WL, et al. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell. 1997;90(1):181-92.
5. Kishida S, Yamamoto H, Ikeda S, Kishida M, Sakamoto I, Koyama S, et al. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin. J Biol Chem. 1998;273:10823-6.
6. Xu HT, Wei Q, Liu Y, Yang LH, Dai SD, Han Y, et al. Over-expression of Axin down-regulates TCF-4 and inhibits the development of lung cancer. Ann Surg Oncol. 2007;14:3251-9.
7. Webster MT, Rozycka M, Sara E, Davis E, Smalley M, Young N, et al. Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding. Gene Chromosome Cancer. 2000;28(4):443-53.
8. Miao J, Kusafuka T, Udatsu Y, Okada A. Sequence variants of the Axin gene in hepatoblastoma. Hepatol Res. 2003;25(2):174-9.
9. Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, et al. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene. 2002;31:4863-71.
10. Shimizu Y, Ikeda S, Fujimori M, Kodama S, Nakahara M, Okajima M, et al. Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability. Gene Chromosome Cancer. 2002;33(1):73-81.
11. Jin LH, Shao QJ, Luo W, Ye ZY, Li Q, Lin SC. Detection of point mutations of the Axin1 gene in colorectal cancers. Int J Cancer. 2003;5:696-9.
12. Nakajima M, Fukuchi M, Miyazaki T, Masuda N, Kato H, Kuwano H. Reduced expression of Axin correlates with tumour progression of oesophageal squamous cell carcinoma. Br J Cancer. 2003;88(11):1734-9.
13. Esteller M. Dormant hypermethylated tumour suppressor genes: questions and answers. J Pathol. 2005;205(2):172-80.
14. Ueta T, Ikeguchi M, Hirooka Y, Kaibara N, Terada T. Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma. Oncol Rep. 2002;9:1197-203.
15. Issa JP, Baylin SB, Herman JG. DNA methylation changes in hematologic malignancies: biologic and clinical implications. Leukemia. 1997;11:7-11.
16. Issa JP. DNA methylation as a clinical marker in oncology. J Clin Oncol. 2012;30(20):2566-8.
17. Raynal NJ, Si J, Taby RF, Gharibyan V, Ahmed S, Jelinek J, et al. DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memory. Cancer Res. 2012;72(5):1170-81.
18. Issa JP, Just W. Epigenetics. FEBS Lett. 2011;585(13):1993.
19. Issa JP. Epigenetic variation and cellular Darwinism. Nat Genet. 2011;43(8):724-6.
20. Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, et al. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin Cancer Res. 2001;7:1998-2003.
21. Zochbauer-Muller S, Minna JD, Gezdm AF. Aberrant DNA methylation in lung cancer: biological and clinical implications. Oncologist. 2002;7:451-7.
22. Yeh KT, Chang JG, Lin TH, Wang YF, Chang JY, Shih MC, et al. Correlation between protein expression and epigenetic and mutation changes of Wnt pathway-related genes in oral cancer. Int J Oncol. 2003;23:1001-7.
23. Oates NA, van Vliet J, Duffy DL, Kroes HY, Martin NG, Boomsma DI, et al. Increased DNA methylation at the AXIN1 gene in a monozygotic twin from a pair discordant for a caudal duplication anomaly. Am J Hum Genet. 2006;79:155-62.
24. Yang LH, Xu HT, Han Y, Li QC, Liu Y, Zhao Y, et al. Axin downregulates TCF-4 transcription via beta-catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells. Mol Cancer. 2010;9:25.